null

SARS-CoV-2 Nucleocapsid Protein Antibody | abx024239

(No reviews yet) Write a Review
SKU:
abx024239
Availability:
Usually shipped in 5 working days
Size:
1 mg
  • SARS-CoV-2 Nucleocapsid Protein Antibody
  • SARS-CoV-2 Nucleocapsid Protein Antibody
€1,082.00
Frequently bought together:

Description

SARS-CoV-2 Nucleocapsid Protein Antibody. Cat# abx024239. Supplier: abbexa.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein (NP) Antibody is a Mouse Monoclonal Antibody against SARS-CoV-2/COVID-19 NP.

The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus’ ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.

It is recommended to use abx024239 (this antibody) as the capture antibody and abx024238 as the detection antibody.

Target Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein
Clonality Monoclonal
Clone M809
Reactivity Virus
Tested Applications ELISA, WB, LF
Host Mouse
Recommended dilutions Optimal dilutions/concentrations should be determined by the end user.
Conjugation Unconjugated
Immunogen Recombinant SARS-CoV-2 Nucleocapsid Protein
Isotype IgG1
Form Liquid
Purity > 95% (SDS-PAGE)
Purification Purified by Protein A chromatography.
Storage Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Buffer PBS, pH 7.4, 0.05% NaN3.
Specificity Specific for SARS-CoV-2 Nucleocapsid Protein. Does not cross-react with MERS-CoV, Human CoV (NL63, 229E, OC43), Human Adenovirus (type 1, 3, 5, 7, 8, 11, 18, 23), Human Parainfluenza Virus (type 1, 2, 3, 4), Human Rhinovirus (type 1, 14, 42), Human Metapneumovirus, Respiratory Syncytial Virus A or Respiratory Syncytial Virus B. Cross-reacts with SARS-CoV (SARS 2003).
Concentration 3.13 mg/ml
Directions for use Centrifuge before opening to ensure complete recovery of vial contents.
Availability Shipped within 5-10 working days.
Note This product is for research use only.
View AllClose

Related Products